ELIZA ADHIKARI: Open Payments
NPI 1962011346 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 10 payments from 9 companies in 2025. Trend: 2023 $108 · 2024 $134 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: REXULTI, Auvelity, TRINTELLIX, WAKIX, INGREZZA, ABILIFY MAINTENA, COBENFY, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
